Abiopharma

New Form 424B2 - JPMORGAN CHASE & CO <b>Filed:</b> 2026-04-16 <b>AccNo:</b> 0001918704-26-010044 <b>Size:</b> 554 KB

New Form 424B2 - BANK OF AMERICA CORP /DE/ <b>Filed:</b> 2026-04-16 <b>AccNo:</b> 0001918704-26-010043 <b>Size:</b> 664 KB

PONY AI INC. (PONY) Files Form 6-K

Examining the issuance of BONDS B; attached is a draft deed of trust and a summary of covenants.

BRAZILIAN ELECTRIC POWER CO (AXIA) Files Form 6-K

New Form 424B2 - UBS AG <b>Filed:</b> 2026-04-16 <b>AccNo:</b> 0001839882-26-020295 <b>Size:</b> 602 KB

(99% Neutral) ABBOTT LABORATORIES (ABT) Reports Q2 2026 Financial Results

(99% Neutral) XILIO THERAPEUTICS, INC. (XLO) Announces New Board Appointment

New Form 424B2 - UBS AG <b>Filed:</b> 2026-04-16 <b>AccNo:</b> 0001839882-26-020293 <b>Size:</b> 604 KB

Paratek Pharmaceuticals to Present New Data on NUZYRA&#174; (omadacycline) at ESCMID Global 2026

Presentation to Investors

New Form 424B2 - JPMORGAN CHASE & CO <b>Filed:</b> 2026-04-16 <b>AccNo:</b> 0001918704-26-010042 <b>Size:</b> 554 KB

Form 8.3

Share Buy Back - Daily Share Buy-Back Notice: Share Buy-Back Notice

(99% Neutral) SOLUNA HOLDINGS, INC (SLNHP) Announces Business Combination